Guangdong Hybribio Biotech Co., Ltd. (300639)

Overview

Guangdong Hybribio Biotech Co., Ltd. is a pioneering entity focusing on the development, manufacturing, and marketing of nucleic acid molecular diagnostic products primarily targeting hospitals and medical institutes. Since its inception in 2003, the company has established a formidable presence not just within its base in Chaozhou, China, but across a vast geographic expanse that includes the Asia Pacific, South East Asia, the Middle East, Europe, Africa, and South America. Its commitment to innovation in medical diagnostics has propelled it to the forefront of providers in national screening, clinical, and research applications.

Products and Services

The comprehensive range of products and services offered by Guangdong Hybribio Biotech Co., Ltd. encompasses a variety of in-vitro diagnostic kits and devices/instruments equipped with cutting-edge technology, along with exemplary after-sales technical support. The diversity of its offerings ensures wide applicability in healthcare diagnostics, from individual diseases to comprehensive screening panels.

• In-vitro Diagnostic Kits: Tailored for a wide range of diseases and conditions, including but not limited to human papilloma virus (HPV), sexually transmitted diseases (STDs), thalassemia, and prenatal and postnatal conditions, these kits provide reliable and efficient tools for diagnosis.
• STD Real Time PCR Kits: Specialized kits designed for the detection of sexually transmitted diseases using real-time PCR technology, offering high sensitivity and specificity.
• Hepatitis B Virus Real-time PCR Kits: These kits utilize real-time PCR methods for the accurate detection and quantification of Hepatitis B virus, facilitating effective disease management.
• Thalassemia Genoarray Diagnostic Kits: Designed for the genetic screening and diagnosis of thalassemia, these kits enable precise genotypic analysis and help in disease management and counseling.
• Hearing Loss Susceptibility Genoarray Diagnostic Kits: These kits provide genetic analysis related to susceptibility to hearing loss, aiding in early diagnosis and intervention strategies.
• COVID-19 Real-time PCR Kits: Developed in response to the global pandemic, these kits offer swift and accurate detection of the SARS-CoV-2 virus, contributing significantly to controlling the spread of the disease.
• Devices/Instruments: The company manufactures and supplies a variety of essential laboratory equipment, including automated nucleic acid extraction systems, automatic medical PCR analysis units, flow-through hybridization systems, auto DNA extraction machines, and fluorescent quantitative detection platforms. These instruments are crucial in the automated, high-throughput processing of samples for molecular diagnostic analysis.
• After-sales Technical Service Support: Guangdong Hybribio Biotech Co., Ltd. complements its product offerings with high-quality after-sales technical service support, ensuring that clients can maximize the utility and efficiency of their purchased products.